Abbott Laboratories Whale Trades For October 06
A whale with a lot of money to spend has taken a noticeably bullish stance on Abbott Laboratories.
Looking at options history for Abbott Laboratories (NYSE:ABT) we detected 10 strange trades.
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.74% on an annualized basis producing an average annual return of 11.68%. Currently, Abbott Laboratories has a market capitalization of $179.27 billion.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 361 companies set new 52-week lows.
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…
Looking Into Abbott Laboratories’s Recent Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 7.32% since its last report. The company recently reported that it has 12.94 million shares sold short, which is 0.76% of all regular shares that are available for trading.
FDA Concludes Oversight Shortcomings After Infant Formula Internal Review
The FDA concluded an internal review of agency actions related to the U.S. infant formula supply.
Weekend Stock Spotlight: Netflix, Meta, NVIDIA, Disney And The Battle For The Stable Coin Market
Benzinga reviews this weekend's top stories covered by leading media outlets, here are the articles investors need to read.
FDA Warns of Clip Lock Malfunctions With Abbott’s MitraClip Heart Valve Devices
The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories (NYSE: ABT) MitraClip's delivery system to stop heart valve leakage.